1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	68_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	de	de	SPS00	C0332285	atributo	6-8	68_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	76	76		-	-	9-11	68_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	68_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	con	con	SPS00	C0332287	atributo	17-20	68_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	obesidad	obesidad	NCFS000	C0028754#C0451819#C1563743	trastorno	21-29	68_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
7	y	y	CC	C1706368	calificador	30-31	68_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
8	diabetes	diabetes	NCFN000	-	-	32-40	68_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
9	mellitas	mella	NCFP00V	-	-	41-49	68_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	8	2192	Modif
10	tipo	tipo	NCMS000	C0441730_1	calificador_1	50-54	68_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	8	2192	Modif
11	2	2	Z	C0441730_2	calificador_2	55-56	68_QUEST_clinical_caseMIR	SENT1	I-Calificador	-	10	97	MultiE
12	en	en	SPS00	C1720294#C0332285	calificador#atributo	57-59	68_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
13	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	60-71	68_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
14	con	con	SPS00	C0332287	atributo	72-75	68_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
15	metformina	metformina	NC00SC0	C0025598	producto#sustancia	76-86	68_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
16	.	.	Fp	-	-	86-87	68_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	Acude	acudir	VMIP3S0	-	-	88-93	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	a	a	SPS00	-	-	94-95	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	urgencias	urgencia	NCFP000	C0439609	calificador	96-105	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	porque	porque	CS	-	-	106-112	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	desde	desde	SPS00	-	-	113-118	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
6	hace	hacer	VMIP3S0	-	-	119-123	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
7	3	3	Z	-	-	124-125	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
8	días	d	NCMP000	-	-	126-130	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
9	presenta	presentar	VMIP3S0	-	-	131-139	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
10	fiebre	fiebre	NCFS000	C0015967	hallazgo	140-146	68_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
11	de	de	SPS00	C0332285	atributo	147-149	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
12	38ºC	38ºC		-	-	150-154	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
13	,	,	Fc	-	-	154-155	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
14	poliaquiuria	poliaquiuria	NC00SC0	C0042023	hallazgo	156-168	68_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
15	,	,	Fc	-	-	168-169	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
16	disuria	disuria	NCFS000	C0013428	hallazgo	170-177	68_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
17	,	,	Fc	-	-	177-178	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
18	intensa	intenso	AQ0FS0	C0205178	calificador	179-186	68_QUEST_clinical_caseMIR	SENT2	B-Calificador	-	-	-	-
19	sed	sed	NCFS000	C0039971	función	187-190	68_QUEST_clinical_caseMIR	SENT2	I-Calificador	-	18	101	MultiE
20	y	y	CC	C1706368	calificador	191-192	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
21	disminución	disminución	NCFS000	C0333668#C0547047	anomalía_morfológica#calificador	193-204	68_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
22	progresiva	progresivo	AQ0FS0	C0205329	calificador	205-215	68_QUEST_clinical_caseMIR	SENT2	B-Calificador	-	21	2193	Modif
23	del	del	SP+DA	-	-	216-219	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
24	nivel	nivel	NCMS000	C0234425_1	entidad_observable_1	220-225	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
25	de	de	SPS00	C0234425_2	entidad_observable_2	226-228	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
26	consciencia	consciencia	NCFS000	C0234425_3	entidad_observable_3	229-240	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
27	.	.	Fp	-	-	240-241	68_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	242-244	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	la	el	DA0FS0	-	-	245-247	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	exploración	exploración	NCFS000	C0031809_1	procedimiento_1	248-259	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	física	físico	NCFS000	C0031809_2	procedimiento_2	260-266	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
5	se	se	P00CN000	-	-	267-269	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
6	aprecian	apreciar	VMIP3P0	-	-	270-278	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
7	signos	signo	NCMP000	C0311392	hallazgo	279-285	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
8	de	de	SPS00	C0332285	atributo	286-288	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
9	deshidratación	deshidratación	NCFS000	C0011175	trastorno	289-303	68_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
10	,	,	Fc	-	-	303-304	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
11	PA	pa	NC00YL0	-	-	305-307	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
12	de	de	SPS00	C0332285	atributo	308-310	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
13	95/54	95/54	Z	-	-	311-316	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
14	mm	mm	NCMN000	-	-	317-319	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
15	Hg	hectogramo	NCMN000	-	-	320-322	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
16	y	y	CC	C1706368	calificador	323-324	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
17	no	no	RN	C1298908	calificador	325-327	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
18	hay	haber	VMIP3S0	-	-	328-331	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
19	signos	signo	NCMP000	C0311392	hallazgo	332-338	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
20	de	de	SPS00	C0332285	atributo	339-341	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
21	localidad	localidad	NCFS000	-	-	342-351	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
22	neurológica	neurológico	AQ0FS0	C0205494	calificador	352-363	68_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-	-	-	-
23	.	.	Fp	-	-	363-364	68_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	365-367	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
2	la	el	DA0FS0	-	-	368-370	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
3	analítica	analítica	NCFS000	-	-	371-380	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
4	destaca	destacar	VMIP3S0	-	-	381-388	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
5	leucocitosis	leucocitosis	NCFN000	C0023518#C0750426	trastorno#hallazgo	389-401	68_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-	-	-	-
6	,	,	Fc	-	-	401-402	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
7	creatinina	creatinina	NC00SC0	C0010294	sustancia	403-413	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
8	de	de	SPS00	C0332285	atributo	414-416	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
9	1,8	1.8	Z	-	-	417-420	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
10	mg	mg	NCMN000	-	-	421-423	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
11	/	/	Fh	-	-	423-424	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
12	dL	decilitro	NCMN000	C0439241	calificador	424-426	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
13	y	y	CC	C1706368	calificador	427-428	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
14	glucemia	glucemia	NCFS000	C2585282	entidad_observable	429-437	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
15	de	de	SPS00	C0332285	atributo	438-440	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
16	855	855	Z	-	-	441-444	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
17	mg	mg	NCMN000	-	-	445-447	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
18	/	/	Fh	-	-	447-448	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
19	dL	decilitro	NCMN000	C0439241	calificador	448-450	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
20	.	.	Fp	-	-	450-451	68_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-

1	¿	¿	Fia	-	-	452-453	68_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
2	Cuál	cuál	PT0CS000	-	-	453-457	68_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
3	es	ser	VSIP3S0	-	-	458-460	68_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
4	el	el	DA0MS0	-	-	461-463	68_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
5	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	464-475	68_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
6	mas	mas	CC	-	-	476-479	68_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
7	probable	probable	AQ0CS0	C0332148	calificador	480-488	68_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
8	?	?	Fit	-	-	488-489	68_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
9	.	.	Fp	-	-	489-490	68_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-

